We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Can Organ-on-a-Chip Technology Really Replace Animal Testing of Drug and Chemical Safety

Video   Oct 18, 2016

 

There is currently great interest in applying microfluidics technology to the construction of complex in vitro models with the eventual goal of simulating the behaviour of an organ or even a whole organism. The enthusiasm for microtechnology has been generated by past success in scaling cell culture from a petri dish down to the current multiple well plates. However our gold standard for clinical response is the human body, which incorporates functional units that require larger scale. It is widely recognised that 3D cell cultures are more representative of human physiology than 2D monolayers of cells growing on a flat surface. Correct organ function also requires gradients of oxygen and metabolites and removal of waste material, as well as co-culture of multiple cell types- hence advanced and accurate models also require flow of media. Any technology which aims to replace animal based methods for safety and toxicity testing will have to meet the following requirements: •Systemic models •Long term and repeat dose exposure •Maintain homeostasis (before insult) •Good disease models The goal for organ-on-a- chip is to accurately mimic clinical behaviour. Once this milestone is achieved then models must demonstrate robustness, repeatability and ease of use, and be economic compared with alternative methods. It is suggested here that the currently available meso-scale Quasi Vivo® technology is a useful stepping stone on the route to the ultimate micro-scale miniaturisation, by acting as a physiologically relevant ‘breadboarding’ tool to aid development of co-culture and long term models with full metabolic capability.

 
 
 
Advertisement
 

Recommended Videos

Intestinal Organoids Grow and Function Like Real Tissues

Video

Bioengineers at EPFL have created miniature intestines in a dish that match up anatomically and functionally to the real thing better than any other lab-grown tissue models.

WATCH NOW

Teach Me in 10 – Engineering a Decoy Receptor for SARS-CoV-2 With Dr Erik Procko, Part II

Video

Dr Erik Procko has been working on engineering a "decoy" receptor for SARS-CoV-2, the virus that has caused the COVID-19 global pandemic. In the second video of this two-part installment, Dr Procko discusses his research in exploring the mutational landscape of ACE2 to further understand the interaction between the receptor and the S protein of SARS-CoV-2.

WATCH NOW


 

Like what you just watched? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE